Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “asthma”

Remote Monitoring of Asthma in Children and Young PeopleRecruiting
NCT07129616N/AUpdated Jan 22, 2026
Sponsor: University of Edinburgh
Asthma Childhood · Asthma Attack · Remote Monitoring · Risk Assessment
United Kingdom
Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic CoughRecruiting
NCT05110144Phase 2Updated Jan 21, 2026
Sponsor: Mayo Clinic
Refractory Chronic Cough
United States
French Validation of the CAPTURE Case Finding Tool for Obstructive Respiratory DiseaseTerminated
NCT05654597N/AUpdated Jan 21, 2026
Sponsor: Groupe Hospitalier du Havre
Lung Diseases · Lung Diseases, Obstructive · Obstructive Pulmonary Disease
France
Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma CentresCompleted
NCT06455462N/AUpdated Jan 21, 2026
Sponsor: AstraZeneca
Severe Asthma
United Kingdom
Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)Active Not Recruiting
NCT06189742Phase 2Updated Jan 20, 2026
Sponsor: Dr. Anne Ellis
Asthma With Allergic Rhinitis
Canada
The Effect of Buteyko Breathing Technique on Asthma PatientsCompleted
NCT07353242NAUpdated Jan 20, 2026
Sponsor: University of Gaziantep
Asthma
Turkey (Türkiye)
Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation SyndromeNot Yet Recruiting
NCT07352488NAUpdated Jan 20, 2026
Sponsor: Henan University of Traditional Chinese Medicine
Allergic Asthma
China
Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and AdolescentsActive Not Recruiting
NCT05347771Phase 2Updated Jan 20, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Asthma
United States
Asthma, Inflammation and G Protein-coupled Receptors (GPCR)Completed
NCT00793676NAUpdated Jan 20, 2026
Sponsor: University Hospital, Strasbourg, France
Asthma · COPD
France
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or DfRecruiting
NCT07348302Phase 3Updated Jan 16, 2026
Sponsor: Inmunotek S.L.
Rhinitis · Rhinoconjunctivitis
Argentina, China, Portugal, Spain
Microbes and Respiratory IllnessesCompleted
NCT06059027N/AUpdated Jan 16, 2026
Sponsor: University of Wisconsin, Madison
Virus · Asthma
United States
Metformin IN Asthma for Overweight and Obese Individuals (MINA)Recruiting
NCT06273072Phase 2Updated Jan 16, 2026
Sponsor: Johns Hopkins University
Asthma · Asthma Chronic · Overweight and Obesity
United States
Asthma in PregnancyCompleted
NCT05047419N/AUpdated Jan 16, 2026
Sponsor: Linnea Polgreen
Asthma · Pregnancy
United States
Probiotics and Insulin Resistance in Obese AsthmaticsActive Not Recruiting
NCT05949255NAUpdated Jan 16, 2026
Sponsor: University of Alabama at Birmingham
Asthma · Obesity · Insulin Resistance
United States
Anti-Inflammatory Reliever South AfricaRecruiting
NCT06429475Phase 3Updated Jan 15, 2026
Sponsor: University of KwaZulu
Asthma
South Africa
Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma PatientsRecruiting
NCT07342803Phase 2Updated Jan 15, 2026
Sponsor: Longbio Pharma
Allergic Asthma
China
Respiratory Outcome of Children From the FEPED CohortCompleted
NCT03229317N/AUpdated Jan 15, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
Asthma in Children
France
An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)Completed
NCT05243680Phase 3Updated Jan 15, 2026
Sponsor: GlaxoSmithKline
Asthma
United States, Australia, Canada, China, Czechia +9 more
Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPAEnrolling By Invitation
NCT07343661Phase 4Updated Jan 15, 2026
Sponsor: Azienda Ospedaliero Universitaria di Cagliari
EGPA - Eosinophilic Granulomatosis With Polyangiitis · Severe Asthma · Eosinophilic Asthma
Italy
Expressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic PatientsRecruiting
NCT06427018N/AUpdated Jan 14, 2026
Sponsor: Lei-Miao Yin
Asthma · Protein
China
Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIALRecruiting
NCT06392776NAUpdated Jan 14, 2026
Sponsor: Ottawa Hospital Research Institute
COPD · Asthma
Canada
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled AsthmaCompleted
NCT05251259Phase 2Updated Jan 14, 2026
Sponsor: AstraZeneca
Asthma
United States, Argentina, Australia, Bulgaria, Chile +15 more
The Effects of Breathing Exercises and Postural Exercises in Young Adults With Asthma.Completed
NCT06504758NAUpdated Jan 14, 2026
Sponsor: Yeditepe University
Asthma
Turkey (Türkiye)
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled AsthmaCompleted
NCT03215758Phase 3Updated Jan 13, 2026
Sponsor: Novartis Pharmaceuticals
Asthma
United States, Argentina, Germany, Hungary, Mexico +5 more
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled AsthmaCompleted
NCT03226392Phase 3Updated Jan 13, 2026
Sponsor: Novartis Pharmaceuticals
Asthma
United States, Brazil, Bulgaria, Canada, Colombia +13 more

Previous page Next page